Skip to content

Arcos Interlocking Distal Stems

by Biomet Manufacturing Corp

510(k) K100469

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK100469 Date7 Dec 2010ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KWA
Device Class
Class III
Regulation
21 CFR Part 888.3330
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Arcos Interlocking Distal Stems are semi-constrained, uncemented acetabular components designed for hip arthroplasty. These metallic implants are intended to provide structural support and stability within the proximal femur, facilitating load-bearing and joint function in orthopedic procedures.

These stems are supplied as reusable medical devices and are regulated under FDA 510(k) clearance (K100469) as Class III orthopedic prostheses. They are manufactured by Biomet Manufacturing Corp. and must be handled in sterile conditions, adhering to standard surgical protocols for hip replacement procedures. Multiple sizes and variants are available, as indicated by the listed FEI numbers.

Other devices from Biomet Manufacturing Corp

See all devices from Biomet Manufacturing Corp →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are the Arcos Interlocking Distal Stems designed for single-use or can they be reused in multiple procedures?

    The Arcos Interlocking Distal Stems are explicitly labeled as reusable medical devices in the provided data. This means they are intended for multiple uses in orthopedic procedures, provided they are handled and sterilized according to standard surgical protocols for hip replacement implants. Reuse must comply with manufacturer guidelines and regulatory requirements to ensure patient safety and device integrity.

  • What types of sterility precautions should be taken when handling these stems, and why?

    The Arcos Interlocking Distal Stems must be handled in sterile conditions, as indicated in the data. This is because they are metallic implants used in hip arthroplasty, where contamination could compromise patient safety. Sterility is critical to prevent infection and ensure the device’s structural integrity during surgery. Always follow Biomet’s sterilization instructions and adhere to standard surgical aseptic techniques.

  • How many sizes or variants of the Arcos Interlocking Distal Stems are available, and how are they identified?

    The Arcos Interlocking Distal Stems come in multiple sizes and variants, each identified by unique FEI numbers (e.g., 3020282716, 3007923096, etc.). The data lists over 50 distinct FEI numbers, which correspond to different stem designs or dimensions. These identifiers help surgeons select the appropriate size for the patient’s anatomy and surgical needs.

  • What regulatory pathway was followed for FDA clearance of these stems, and what does that mean for clinicians?

    The Arcos Interlocking Distal Stems were cleared through the FDA 510(k) process (K100469) under the Traditional Review pathway, classified as Class III orthopedic prostheses. This means the device was determined to be substantially equivalent to a legally marketed predicate, ensuring it meets FDA safety and effectiveness standards for semi-constrained, uncemented acetabular components. Clinicians can rely on this clearance as evidence of regulatory scrutiny for use in hip arthroplasty.